ストックスクリーナーアプリを入手
102.98
0.59%
0.60
前日終値:
$102.38
開ける：
$102.28
24時間の取引高:
1.04M
Relative Volume:
0.41
時価総額：
$13.37B
収益：
$692.26M
当期純損益:
$-512.41M
株価収益率:
-24.29
EPS:
-4.24
ネットキャッシュフロー:
$-274.36M
1週間 パフォーマンス:
+3.25%
1か月 パフォーマンス:
-4.46%
6か月 パフォーマンス:
+105.84%
1年 パフォーマンス:
+228.28%
1日の値動き範囲:
$101.50
$104.75
1週間の範囲:
$99.77
$104.75
52週間の値動き範囲:
$29.91
$112.42
Guardant Health Inc Stock (GH) Company Profile
GH を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
GH
Guardant Health Inc
|
102.98 | 13.30B | 692.26M | -512.41M | -274.36M | -4.24 |
|
TMO
Thermo Fisher Scientific Inc
|
580.74 | 217.58B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
230.32 | 163.50B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
688.48 | 54.95B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
138.39 | 39.21B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
IQV
Iqvia Holdings Inc
|
226.92 | 38.49B | 15.90B | 1.28B | 2.21B | 7.2842 |
Guardant Health Inc Stock (GH) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-02 | 再開されました | Morgan Stanley | Overweight |
| 2025-09-25 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2025-09-22 | 再開されました | Wells Fargo | Overweight |
| 2025-04-10 | 開始されました | Mizuho | Outperform |
| 2025-01-23 | 開始されました | Barclays | Overweight |
| 2024-06-28 | アップグレード | Guggenheim | Neutral → Buy |
| 2024-06-03 | 再開されました | Jefferies | Buy |
| 2024-04-24 | 再開されました | Craig Hallum | Buy |
| 2023-12-14 | 開始されました | Guggenheim | Neutral |
| 2023-12-13 | 開始されました | Wolfe Research | Peer Perform |
| 2023-11-13 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2023-09-28 | 開始されました | Bernstein | Outperform |
| 2023-09-27 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2023-07-05 | 再開されました | JP Morgan | Overweight |
| 2023-05-26 | アップグレード | Citigroup | Neutral → Buy |
| 2023-05-05 | 開始されました | UBS | Buy |
| 2023-03-09 | ダウングレード | Citigroup | Buy → Neutral |
| 2023-01-05 | 開始されました | Scotiabank | Sector Outperform |
| 2022-11-01 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2022-10-19 | 開始されました | Craig Hallum | Buy |
| 2022-10-06 | 開始されました | Stephens | Overweight |
| 2022-08-25 | 開始されました | Credit Suisse | Outperform |
| 2022-06-03 | 開始されました | Piper Sandler | Overweight |
| 2022-04-28 | 再開されました | BTIG Research | Buy |
| 2022-02-24 | 繰り返されました | Canaccord Genuity | Buy |
| 2022-02-24 | 繰り返されました | Citigroup | Buy |
| 2022-02-24 | 繰り返されました | Cowen | Outperform |
| 2022-02-24 | 繰り返されました | Morgan Stanley | Overweight |
| 2022-02-24 | 繰り返されました | SVB Leerink | Outperform |
| 2022-02-24 | 繰り返されました | Stifel | Buy |
| 2022-02-24 | 繰り返されました | Wells Fargo | Overweight |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2021-06-15 | 開始されました | Raymond James | Mkt Perform |
| 2021-06-03 | 開始されました | Goldman | Buy |
| 2021-05-25 | 開始されました | Wells Fargo | Overweight |
| 2021-01-11 | 開始されました | Stifel | Buy |
| 2020-09-09 | 開始されました | Morgan Stanley | Overweight |
| 2020-06-12 | 開始されました | BTIG Research | Buy |
| 2020-02-21 | 開始されました | Guggenheim | Buy |
| 2020-01-07 | 開始されました | Citigroup | Buy |
| 2019-08-07 | 繰り返されました | Canaccord Genuity | Buy |
| 2019-04-16 | 開始されました | Canaccord Genuity | Buy |
| 2019-04-10 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2019-02-28 | 繰り返されました | BofA/Merrill | Neutral |
| 2018-10-29 | 開始されました | BofA/Merrill | Neutral |
| 2018-10-29 | 開始されました | JP Morgan | Overweight |
| 2018-10-29 | 開始されました | William Blair | Outperform |
すべてを表示
Guardant Health Inc (GH) 最新ニュース
Multiple analysts lift Guardant Health, Inc. (GH) targets on screening and data growth - MSN
Capricorn Fund Managers Ltd Takes $2.26 Million Position in Guardant Health, Inc. $GH - MarketBeat
Guardant Health, Inc. (NASDAQ:GH) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Guardant Health, Inc. (NASDAQ:GH) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Genomics in Cancer Care Market to Reach USD 72.87 Billion by 2033 | - openPR.com
What analysts say about Guardant Health Inc stockGlobal Trade Effects & Access High Yield Alerts - earlytimes.in
Multiple Analysts Lift Guardant Health, Inc. (GH) Targets on Screening and Data Growth - Yahoo Finance
Guardant Health (GH) Leads Healthcare Stocks with 226.48% YTD Ga - GuruFocus
Guardant Health is the top performing healthcare services stock YTD (GH:NASDAQ) - Seeking Alpha
7 Most Promising Gene Editing Stocks According to Analysts - Insider Monkey
Guardant Health (GH) Receives Buy Rating and $125 Price Target f - GuruFocus
Canaccord Genuity Group Issues Positive Forecast for Guardant Health (NASDAQ:GH) Stock Price - MarketBeat
Guardant Health Japan receives regulatory approval of Guardant360® CDx liquid biopsy as companion diagnostic for imlunestrant in metastatic or recurrent breast cancer previously treated with endocrine therapy - Yahoo Finance
(GH) Volatility Zones as Tactical Triggers - news.stocktradersdaily.com
Why Guardant Health Inc. (5GH) stock could be top winnerWeekly Investment Recap & Weekly Momentum Picks - ulpravda.ru
How Guardant Health Inc. (5GH) stock reacts to stronger dollarGap Up & Weekly Sector Rotation Insights - DonanımHaber
First Week of February 2026 Options Trading For Guardant Health (GH) - Nasdaq
How strong is Guardant Health Inc. stock balance sheetJuly 2025 Highlights & Weekly Breakout Stock Alerts - DonanımHaber
Can Guardant Health Inc. (5GH) stock hold up in economic slowdown2025 Big Picture & Low Drawdown Trading Techniques - DonanımHaber
Insider Sell: Musa Tariq Sells Shares of Guardant Health Inc (GH) - GuruFocus
Guardant Health (GH) CIO reports RSU vesting and tax-share withholding - Stock Titan
Guardant Health Insider Move Sparks Fresh Buzz on Wall Street - TipRanks
[Form 4] Guardant Health, Inc. Insider Trading Activity - Stock Titan
Guardant Health (GH) CMO Craig Eagle reports RSU vesting and tax share sale - Stock Titan
Guardant Health (NASDAQ:GH) Director Sells $11,769.36 in Stock - MarketBeat
Dir Tariq Sells 116 ($11.8K) Of Guardant Health Inc [GH] - TradingView — Track All Markets
Guardant Health (GH) director exercises RSUs into 232 common shares - Stock Titan
Guardant Health (GH) director reports 116-share stock sale and holdings - Stock Titan
Will Guardant Health Inc. stock deliver better than expected guidance2025 Key Lessons & Proven Capital Preservation Tips - Улправда
Guardant Health Insider Sold Shares Worth $9,402,220, According to a Recent SEC Filing - marketscreener.com
Insider Sell: Helmy Eltoukhy Sells 90,565 Shares of Guardant Hea - GuruFocus
Analysts Are Bullish on Top Healthcare Stocks: Guardant Health (GH), Natera (NTRA) - The Globe and Mail
Insider Selling: Guardant Health (NASDAQ:GH) CEO Sells $9,402,458.30 in Stock - MarketBeat
Guardant Health (NASDAQ:GH) CTO Sells $567,122.04 in Stock - MarketBeat
Officer Freeman Acquires 808 Of Guardant Health Inc [GH] - TradingView — Track All Markets
Guardant Health Executives Sell Shares Worth Millions - TradingView — Track All Markets
Officer Chudova Sells 5,451 ($567.1K) Of Guardant Health Inc [GH] - TradingView — Track All Markets
Dir Tariq Files To Sell 116 Of Guardant Health Inc [GH] - TradingView — Track All Markets
Guardant Health (NASDAQ:GH) Price Target Raised to $120.00 - MarketBeat
GH: Mizuho Maintains Outperform Rating, Raises Price Target to $120 | GH Stock News - GuruFocus
Guardant Health, Inc. $GH Holdings Boosted by Sicart Associates LLC - MarketBeat
Oncology Biotech Challenges Rival's Cancer Testing Patent - Law360
Guardant Health price target raised to $120 from $100 at BofA - Yahoo Finance
State of Wyoming Takes $567,000 Position in Guardant Health, Inc. $GH - MarketBeat
JP Morgan Maintains Guardant Health (GH) Overweight Recommendation - MSN
Guardant Health (GH) Sees Positive Analyst Rating from Barclays - GuruFocus
Analyst JP Morgan Raises Price Target for Guardant Health (GH) | - GuruFocus
Guardant Health (NASDAQ:GH) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says - MarketBeat
Guardant Health (GH) Receives Raised Price Target from Wells Far - GuruFocus
Guardant Health (GH): Reassessing Valuation After a Sharp Share Price Recovery - Yahoo Finance
Nikko Asset Management Americas Inc. Raises Stake in Guardant Health, Inc. $GH - MarketBeat
Guardant Health Inc (GH) 財務データ
収益
当期純利益
現金流量
EPS
0.27%
0.32%
大文字化:
|
ボリューム (24 時間):